Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYCRISPR Therapeutics to Present at Upcoming Investor ConferencesPREV STORYU.S. FDA Grants Priority Review for Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication